|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
8 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Cost of goods sold (exclusive of depreciation) | |||||
| Inventory impairment | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Share-based compensation expense | |||||
| Depreciation | |||||
| Loss (gain) on asset disposal | |||||
| Other loss | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest expense | |||||
| Nonrelated Party | |||||
| Related party | |||||
| Interest expense | |||||
| Interest expense (income), net | |||||
| Change in fair value of convertible notes | |||||
| Tariff refund | |||||
| Change in fair value of warrants liabilities | |||||
| Loss on financing transaction | |||||
| Other expense (income), net | |||||
| Total income (or loss) before income tax expense (or benefit) | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Weighted-average shares outstanding, basic and diluted | |||||
| Basic (in shares) | |||||
| Total basic (in shares) | |||||
| Diluted (in shares) | |||||
| Total diluted (in shares) | |||||
| Net loss per share, basic and diluted | |||||
| Basic (in dollars per shares) | |||||
| Total basic (in dollars per shares) | |||||
| Diluted (in dollars per shares) | |||||
| Total diluted (in dollars per shares) | |||||
Loading...